In the BioHarmony Drug Report Database

"Preview" Icon

Octocrylene

Anthelios Sx, Capital Soleil (octocrylene) is a small molecule pharmaceutical. Octocrylene was first approved as Anthelios Sx on 2006-07-21.

 

Trade Name

 

Anthelios Sx, Capital Soleil
 

Common Name

 

octocrylene
 

ChEMBL ID

 

CHEMBL1201147
 

Indication

 

 

Drug Class

 

Image (chem structure or protein)

Octocrylene structure rendering